Product Overview

Artesunate Injection IP 60 mg is an injectable antimalarial formulation developed for the treatment of severe malaria. It provides rapid antimalarial activity by acting against the blood-stage forms of malaria parasites.

Artesunate is rapidly converted into dihydroartemisinin after administration. The active metabolite exerts potent antimalarial effects, helping reduce the number of parasites in the bloodstream and supporting rapid control of severe malaria.

The formulation is intended for intravenous or intramuscular administration by qualified healthcare professionals. The dosage and frequency are determined according to the patient’s body weight, clinical condition, and treatment guidelines.

Key Features

• Rapid-acting antimalarial
• Designed for severe malaria management
• Suitable for intravenous and intramuscular administration
• Helps rapidly reduce parasite levels
• Convenient injectable presentation

Uses

• Severe malaria
• Malaria requiring injectable treatment
• Parenteral antimalarial therapy under medical supervision

How It Works

Artesunate is converted to dihydroartemisinin, which acts against malaria parasites in their blood stage and helps reduce parasite levels rapidly.

Possible Side Effects

• Nausea
• Vomiting
• Headache
• Dizziness
• Injection-site reactions
• Changes in blood cell counts

Precautions

• Administer only under medical supervision
• Use by qualified healthcare professionals
• Monitor the patient appropriately during treatment
• Follow injectable Artesunate with the recommended complete antimalarial treatment
• Do not self-administer

Storage Instructions

Store in a cool, dry place protected from light and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.